(2R,3S,4R,5R,6R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-(4-hydroxyphenethoxy)tetrahydro-2H-pyran-3-yl (E)-3-(4-hydroxyphenyl)acrylate

Catalog No. :
ACYJDD178
CAS No. :
97457-19-7
Molecular Formula :
C23H26O9
Molecular Weight :
446.45

IUPAC Name:(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-hydroxyphenethoxy)tetrahydro-2H-pyran-3-yl (E)-3-(4-hydroxyphenyl)acrylate

(2R,3S,4R,5R,6R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-(4-hydroxyphenethoxy)tetrahydro-2H-pyran-3-yl (E)-3-(4-hydroxyphenyl)acrylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3S,4R,5R,6R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-(4-hydroxyphenethoxy)tetrahydro-2H-pyran-3-yl (E)-3-(4-hydroxyphenyl)acrylate
IUPAC Name(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-hydroxyphenethoxy)tetrahydro-2H-pyran-3-yl (E)-3-(4-hydroxyphenyl)acrylate
Molecular FormulaC23H26O9
Molecular Weight446.45
SMILESO(C(/C=C/C1=CC=C(O)C=C1)=O)[C@@H]2[C@@H](CO)O[C@@H](OCCC3=CC=C(O)C=C3)[C@H](O)[C@H]2O
InChI KeyTXIKDCCKEBXQGU-WYSYKVOOSA-N
Synonymβ-D-Glucopyranoside, 2-(4-hydroxyphenyl)ethyl, 4-[(2E)-3-(4-hydroxyphenyl)-2-propenoate];osmanthuside A
CAS No.97457-19-7

Synthetic Route by SureRoute

1. ACYJDD178 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRZDC412 route compound structure diagram
    ACRZDC412123-08-0 In Stock
  4. Then
  5. ACYJDD178 route product structure diagram
    ACYJDD17897457-19-7
Inquiry

2. ACYJDD178 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRZDC412 route compound structure diagram
    ACRZDC412123-08-0 In Stock
  4. Then
  5. ACYJDD178 route product structure diagram
    ACYJDD17897457-19-7
Inquiry

Comments (0)